Case report · 10 Aug 2026
Review articlePublished 26 Oct 2022
Post-COVID Long-Term Complications in Human
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our world is experiencing the passage through the post-COVID phase. Post-COVID syndrome known as “long COVID” refers to symptoms persisting for more than three weeks after the diagnosis of COVID-19 in a human subject. The main clinical presentations of COVID-19 include respiratory distress, shortness of breathing, muscle fatigability, fever, sneezing, loss of smell or taste, sore throat and pain associated with these conditions. A high portion of patients, who recovered this disease already, can manifest a plethora of long-lasting symptoms. Mostly, 25% of patients having COVID-19 may have characteristics extending beyond three weeks, and thus exhibiting the criteria of post-COVID syndrome. In this connection, primary healthcare providers can play a vital role in the management of patients with post-COVID syndrome. Although, many patients fully recover, health complications can delay a person’s complete return to a regular lifestyle. To resume normal life, COVID-19 survivors are required to take aid to routine consultations, physiotherapy, and dermatological care. Our focus of this review is not to limited only on the epidemiology, pathophysiology, and actual clinical characteristics for the various long-term syndromes that have been observed in each organ system in human body following the infection with SARS-CoV-2, but also to consider future directions, with regards to newer variants of this deadly virus and their potential impact on the longterm complications observed.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Trials.
Short communication · 31 Jul 2026
Understanding Bioavailability as a Key Element in Effective Therapeutic Delivery
Research article · 14 Jun 2026
Ensuring Rights and Dignity in Ethical Practices of Clinical Studies with Vulnerable Group and Safeguarding Vulnerable Group Act (2006)
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Trials
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mir Monir Hossain”
- BylineArticles whose byline prints “Md Hasibur Rahman”
- BylineArticles whose byline prints “Tasmuna Tamrin Tanmy”
- BylineArticles whose byline prints “Mohammad Lutful Kabir”
- BylineArticles whose byline prints “Kazi Nur Uddin”

